![]() |
市場調查報告書
商品編碼
1451725
RFID 血液冰箱和冷凍庫市場報告(按類型(RFID 冰箱、RFID 冰櫃)、應用(醫院和診斷中心、血庫等)和地區)2024-2032 年RFID Blood Refrigerators and Freezers Market Report by Types (RFID Refrigerators, RFID Freezers), Applications (Hospitals and Diagnostic Centers, Blood Banks, and Others), and Region 2024-2032 |
2023年,全球RFID血液冰箱和冰櫃市場規模達到2.914億美元。展望未來, IMARC Group預計到2032年市場規模將達到9.718億美元,2024-2032年複合年成長率(CAGR)為13.89%。
無線射頻識別(RFID)血液冰箱和冰櫃是指先進的溫控儲存系統,用於收集和安全保存各種試劑和血液成分,包括血漿衍生物和紅血球(RBC)。它們包括互連管道、毛細管、冷凝器、膨脹器、蒸發器、電動壓縮機和有助於調節冰箱溫度的恆溫器。一些先進模型還包括配置、壓縮機、馬達和緊急電源系統,以在波動期間提供能量備用。 RFID 血液冰箱和冰櫃可以即時追蹤關鍵的血小板成分及其狀況,並保持產品品質符合食品藥物管理局 (FDA) 法規。除此之外,它們還聰明、使用安全且可靠,有助於最大限度地減少技術錯誤並提高營運效率。因此,醫院和診斷中心使用 RFID 血液冰箱和冷凍庫來儲存血液,以用於測試、儲存、運輸和輸血目的。
包括白血病、地中海貧血和血友病在內的各種慢性疾病的盛行率不斷上升,以及手術後失血發生率的上升,主要推動了市場的成長。與此一致的是,醫院環境中血庫對獲取血漿、樣本和血小板以進行實驗和評估細胞功能的需求不斷增加,這促進了市場上的產品需求。此外,具有由耐腐蝕鋼和手柄組成的抽屜架的先進血液冰箱和冰櫃的出現也是另一個促進成長的因素。此類產品由身份證夾組成,可以儲存過量的血管並在不拆除整個架子的情況下取出血管。此外,政府和非政府組織(NGO)擴大進行計劃和宣傳活動,教育大眾了解捐血的好處和誤解,這有利於市場的成長。除此之外,醫療保健基礎設施的顯著改善、持續的研發(R&D)活動以及持續的產品增強和多樣化正在積極刺激市場成長。
The global RFID blood refrigerators and freezers market size reached US$ 291.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 971.8 Million by 2032, exhibiting a growth rate (CAGR) of 13.89% during 2024-2032.
Radio frequency identification (RFID) blood refrigerators and freezers refer to advanced temperature-controlled storage systems that collect and safely preserve various reagents and blood components, including plasma derivatives and red blood cells (RBCs). They encompass interconnected tubing, a capillary tube, a condenser, expansion, an evaporator, electrically powered compressors, and a thermostat that helps regulate refrigerator temperature. Some advanced models further comprise configurations, compressors, motors, and emergency power systems to provide energy backup during fluctuations. RFID blood refrigerators and freezers allow real-time tracking of critical platelet components and their conditions and maintain the product quality to comply with food and drug administration (FDA) regulations. Apart from this, they are intelligent, safe to use, and reliable and aid in minimizing technical errors and increasing operational efficiency. As a result, RFID blood refrigerators and freezers are used by hospitals and diagnostic centers to store blood for testing, storing, transporting, and transfusion purposes.
The increasing prevalence of various chronic diseases, including leukemia, thalassemia, and hemophilia, and the rising incidences of blood loss post-surgical procedures are primarily driving the market growth. In line with this, the escalating need for blood banks in hospital settings to obtain plasma, samples, and platelets for conducting experiments and assessing cell functions is facilitating the product demand in the market. Additionally, the advent of advanced blood refrigerators and freezers with drawer racks composed of corrosion-resistant steel and handles is acting as another growth-inducing factor. Such products consist of identification cardholders, and they enable the storage of blood tubes in excessive amounts and their retrieval without the removal of the entire rack. Moreover, increasing initiatives and awareness programs by governments and non-governmental organizations (NGOs) toward educating the masses on the benefits and misconceptions of blood donation are favoring the market growth. Apart from this, significant improvements in the healthcare infrastructure, ongoing research and development (R&D) activities, and continuous product enhancements and diversification are positively stimulating the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global RFID blood refrigerators and freezers market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on types and applications.
RFID Refrigerators
RFID Freezers
Hospitals and Diagnostic Centers
Blood Banks
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Angelantoni Life Science Srl, Biomed Global, Cardinal Health Inc., IQM AS, MedSella (MedFlow Clinical Ltd.), Qingdao Haier Biomedical Co Ltd., Rollex Group Australia PTY Ltd., SATO Vicinity Pty Ltd. (SATO Holdings Corporation), Spacecode Technologies, Terso Solutions Inc. (Promega Corporation), Thalheimer Kuhlung GmbH & Co KG and Venture Research Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.